BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19483726)

  • 1. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.
    Dydensborg AB; Rose AA; Wilson BJ; Grote D; Paquet M; Giguère V; Siegel PM; Bouchard M
    Oncogene; 2009 Jul; 28(29):2634-42. PubMed ID: 19483726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
    Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
    Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
    Chou J; Lin JH; Brenot A; Kim JW; Provot S; Werb Z
    Nat Cell Biol; 2013 Feb; 15(2):201-13. PubMed ID: 23354167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation.
    Morales M; Arenas EJ; Urosevic J; Guiu M; Fernández E; Planet E; Fenwick RB; Fernández-Ruiz S; Salvatella X; Reverter D; Carracedo A; Massagué J; Gomis RR
    EMBO Mol Med; 2014 Jul; 6(7):865-81. PubMed ID: 24867881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
    Chu IM; Michalowski AM; Hoenerhoff M; Szauter KM; Luger D; Sato M; Flanders K; Oshima A; Csiszar K; Green JE
    Oncogene; 2012 Apr; 31(16):2017-27. PubMed ID: 21892208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
    Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
    Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Shahi P; Wang CY; Lawson DA; Slorach EM; Lu A; Yu Y; Lai MD; Gonzalez Velozo H; Werb Z
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3169-3174. PubMed ID: 28258171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 in development and cancer differentiation: cells GATA have it!
    Chou J; Provot S; Werb Z
    J Cell Physiol; 2010 Jan; 222(1):42-9. PubMed ID: 19798694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
    Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
    Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.
    Si W; Huang W; Zheng Y; Yang Y; Liu X; Shan L; Zhou X; Wang Y; Su D; Gao J; Yan R; Han X; Li W; He L; Shi L; Xuan C; Liang J; Sun L; Wang Y; Shang Y
    Cancer Cell; 2015 Jun; 27(6):822-36. PubMed ID: 26028330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl hydroxylases are transcription targets for GATA3 driving lung cancer cell metastasis.
    Liu W; Zhang T; Guo L; Wang Y; Yang Y
    Sci Rep; 2018 Aug; 8(1):11905. PubMed ID: 30093726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.
    Li M; Qi Y; Chen M; Wang Z; Zeng D; Xiao Y; Li S; Lin H; Wei X; Zhang G
    Int J Biol Sci; 2019; 15(12):2522-2537. PubMed ID: 31754326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
    McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
    Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.
    Bockhorn J; Prat A; Chang YF; Liu X; Huang S; Shang M; Nwachukwu C; Gomez-Vega MJ; Harrell JC; Olopade OI; Perou CM; Liu H
    Cancer Res; 2014 Dec; 74(24):7406-17. PubMed ID: 25339353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.